Immunotherapies and other cancer treatments don’t work well on “cold” tumors, also known as immunological deserts, because they usually have few T cells.
Antibodies
A team of researchers from Kyushu University has created a novel antibody that targets and inhibits the malfunction of the protein hepatocyte growth factor, or HGF, which is essential for developing, regenerating, and repairing skeletal muscle.
This is the first time that this particular strategy is being applied to develop antibodies for snakebite treatment.
